Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model
Open Access
- 16 December 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 57 (2) , 353-355
- https://doi.org/10.1093/jac/dki456
Abstract
Objectives: To evaluate the efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed Mongolian gerbil (Meriones unguiculatus) model. Methods: Gerbils (1-month-old) were dexamethasone-immunosuppressed for 10 days and challenged orally with 105Cryptosporidium parvum oocysts. From day 0 to day 12 post-infection, one group (n = 14) was treated with 200 mg/kg/day nitazoxanide and another (n = 15) with 100 mg/kg/day paromomycin. Infection and efficacy of nitazoxanide and paromomycin were assessed by measuring oocyst shedding in faeces, biliary tract and ileum histological examination. Results: In nitazoxanide-treated and paromomycin-treated groups as compared with untreated animals (P < 0.05), oocyst shedding was partially suppressed in a similar manner (P > 0.05). Parasites were present in histological sections of the ileal mucosa of 16/16 infected untreated animals versus 3/14 and 6/15 in the nitazoxanide-treated and the paromomycin-treated groups, respectively (P < 0.05). In addition, gall bladder infection was less frequent in nitazoxanide-treated (2/14, P < 0.01) and paromomycin-treated (5/15, P = 0.07) animals than in untreated controls (9/16). No histological alteration of biliary mucosa was observed in both treated and untreated infected gerbils. Conclusions: Present data support the efficacy of nitazoxanide and, to a lesser extent, paromomycin on biliary C. parvum infection in gerbils, and prompt further investigation of the potential clinical benefits of nitazoxanide in treating human biliary cryptosporidiosis.Keywords
This publication has 17 references indexed in Scilit:
- Infectivity of Cryptosporidium hominis and Cryptosporidium parvum Genotype 2 Isolates in Immunosuppressed Mongolian GerbilsInfection and Immunity, 2005
- The X-Linked Hyper-IgM SyndromeMedicine, 2003
- Prognostic Factors for The Survival of Patients With Aids CholangiopathyAmerican Journal of Gastroenterology, 2003
- Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficienciesThe Pediatric Infectious Disease Journal, 2003
- Cryptosporidiosis and the Pathogenesis of AIDS-CholangiopathySeminars in Liver Disease, 2002
- Treatment of Diarrhea Caused byCryptosporidium parvum:A Prospective Randomized, Double‐Blind, Placebo‐Controlled Study of NitazoxanideThe Journal of Infectious Diseases, 2001
- Biliary tract cryptosporidiosis in an immunosuppressed rat modelPublished by Elsevier ,1999
- Evaluation of high-dose regimen of paromomycin against cryptosporidiosis in the dexamethasone-treated rat modelAntimicrobial Agents and Chemotherapy, 1995
- Paromomycin for Cryptosporidiosis in AIDS: A Prospective, Double-Blind TrialThe Journal of Infectious Diseases, 1994
- Natural history of AIDS related sclerosing cholangitis: a study of 20 cases.Gut, 1993